Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TEL vs GSK✓SelectedUSD · GSKTEL vs GSK performance historyLatest closeAs of-0.68%11/13
Stock and ETF performance explorer

TEL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+81.0%
GSK return
+65.8%
Excess return
+15.2%
Maximum drawdown
-22.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%+0.5%-1.2%-0.8%
7D+4.5%+1.1%+3.4%+4.3%
30D+2.9%+6.3%-3.4%+1.9%
3M+1.1%+1.8%-0.7%+0.8%
6M+5.0%+1.7%+3.3%+4.5%
YTD-3.9%+6.5%-10.4%-5.0%
1Y-7.4%+9.5%-16.9%-9.0%
3Y+81.0%+65.3%+15.7%+71.9%
All+81.0%+65.8%+15.2%+71.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling